The client is a publicly traded medical technology company and an early adopter of Oracle Fusion Cloud Applications. The case study does not name it. Its IT and Finance teams manage the Oracle relationship, and its CFO and CEO became involved as the renewal escalated. By late 2024, after years of annual uplifts and unexpected usage charges, the company regarded Oracle as a runaway expense.

By late 2024, Oracle had become a runaway expense for the company. After years of annual uplifts and unexpected usage charges, it faced a 19% increase in annual subscription fees and a three-year renewal quote of $8.7 million. Months of negotiations between the company and Oracle had been unproductive.

Oracle was pushing to move the organization from a la carte pricing to its Suite Professional SKU, effectively priced at full list. Yet the same SKU appeared on the U.S. federal GSA schedule at a 31% discount, directly undercutting Oracle's claim that the renewal offer represented a strong deal.

The pressure was commercial and operational at once. Oracle made multiple threats to terminate the customer's environment if the contract was not signed by its termination date, putting continuity of mission-critical systems and executive credibility at stake. The IT and Finance teams needed a representative who could hold the line against list-price anchoring and escalating sales tactics.

Remend was engaged to lead the negotiation as the organization's primary representative in discussions with Oracle. Its responsibilities included conducting a license and usage audit across Oracle Fusion Cloud Applications, advising on session-level data to identify inactive users and over-subscription, preparing executive communications and quiet-period strategies, and structuring a gainshare-based engagement aligned with financial outcomes.

The company delegated all Oracle communication to Remend. This triggered a predictable escalation within Oracle's sales organization, from a regional director to a vice president and ultimately a senior vice president. As Oracle ratcheted up the pressure, including threats to terminate the environment, Remend guided the customer through both technical and strategic roadblocks.

On the customer side, the engagement began with mid-level IT management. As Oracle's pressure mounted, internal escalation moved to senior directors and ultimately to the CFO, who secured CEO-level approval and finalized the commercial position. Real-time usage analysis uncovered over-subscription, quiet-period strategies neutralized Oracle's pressure tactics, and executive alignment gave the process urgency, focus and accountability.

• Final agreement at $8.0 million, a $700,000 reduction from Oracle's original $8.7 million quote
• Oracle's Suite Professional pricing revealed as list-price anchoring; the same SKU sat on the GSA schedule at a 31% discount
• Real-time usage analysis uncovered inactive users and over-subscription
• Quiet-period strategies neutralized Oracle's pressure tactics, including threats to terminate the environment
• Continuity of mission-critical systems preserved and executive credibility protected